Open sidebar
Reports

Vaccine Coverage (Children): 1st dose

Description
Report on COVID-19 vaccination coverage in England, for all patients aged 5-15 registered with practices that use TPP SystmOne software. UPDATE: we are no longer updating these reports on a regular basis. If you do rely on these reports and data releases in your own work, please get in touch at the email address below.
Contact
Get in touch and tell us how you use this report or new features you'd like to see: team@opensafely.org
First published
08 Jul 2022
Last released
10 Oct 2022
Links

OpenSAFELY COVID Vaccine coverage report: first doses for 5 to 15 year olds

OpenSAFELY is a new secure analytics platform for electronic patient records built on behalf of NHS England to deliver urgent academic and operational research during the pandemic.

Since December 2020 we have been reporting on COVID-19 vaccination coverage (for patients aged 16 and over) in England using data from 40% of general practices that use TPP electronic health record software. In September 2021, the COVID vaccination programme was extended to 12-15 year olds. The Living with Covid guidance was updated in February 2022 to advise that vaccines would be offered to children between the ages of 5 and 11 from Spring 2022. As such, we are now regularly reporting on vaccination coverage for children between the age of 5 and 15.

The data requires careful interpretation and there are a number of caveats, please refer to our peer-reviewed publications (https://doi.org/10.3399/BJGP.2021.0376) for further details. While the publication describes an analysis of vaccine uptake in those 16 and over, it is relevant here as the same methodology has been used to generate our vaccine coverage reports for 5-15 year olds.

The full analytical methods behind the latest results in this report are available here.

Vaccines approved for use in children

The 30 microgram dose of the Pfizer BioNTech COVID-19 vaccine BNT162b2 was approved for use in 12-15 year olds in June 2021. In December 2021, the MHRA approved a 10 microgram dose for children aged 5-11 years. Where the paediatric formulation is not available, 10 micrograms (0.1ml) of the diluted adult vaccine may be used as an alternative. The Moderna vaccine has also been approved for use in 12-17 year olds.

More information regarding vaccines approved for use is available in The Green Book, chapter 14a, see specifically the "Vaccine Effectiveness" (p.6-7) and "Dosing and Schedule" (p. 12-13) sections.

Contents

Vaccinations included up to 10 Aug 2022 inclusive

Report last updated 07 Oct 2022

Group definitions

  • Patient age is calculated on the date of extraction from date of birth; note that, to minimise risk of disclosure, all dates of birth are rounded down to the first of the month in OpenSAFELY.
  • The patients who are 'In a risk group' have been identified using the criteria in Table 4 of the Green Book and codelists from SARS-CoV2 (COVID-19) Vaccine Uptake Reporting Specification Collection 2020/2021 (v1.5.3) as distributed by PRIMIS. This includes patients with:
    • Immunosuppression
    • Chronic kidney disease
    • Chronic liver disease
    • Chronic heart disease
    • Chronic respiratory disease
    • Chronic neurological disease (including stroke/TIA, cerebral palsy, or MS)
    • Asplenia or dysfunction of the spleen
    • Asthma
    • Diabetes
    • Severe mental illness
    • Learning disabilities
    • Pregnancy
  • Any patient who does not belong to a risk group mentioned above are described as 'Not in a risk group'.

Overview of Vaccination Figures to date

first dose as at 10 Aug 2022 second dose as at 10 Aug 2022
Group
Total vaccinated 852,334 529,739
5-11 10.8% (219,163 of 2,022,195) 3.8% (77,259 of 2,022,195)
12-15 53.5% (633,164 of 1,184,008) 38.2% (452,480 of 1,184,008)

Notes

  • Patient counts are rounded to nearest 7

  • Second doses are at least 49 days after the first

  • All second doses given in these timescales are counted whether or not they were 'due' according to the relevant dosing schedule at the time

Brand counts

Note that the total in this table may not be identical to that provided elsewhere and percentages may not sum to 100%. There are several aspects of the recorded data and analysis that impact on these totals:

  • It is not always possible to determine the vaccine type given; these patients are removed from the brand totals
  • Occasionally patients have more than one brand recorded on the same day; these patients are removed from the brand totals
  • We round to seven to mitigate against risk of disclosure; these totals are calculated from previously rounded numbers
First doses as at 10 Aug 2022 % first doses as at 10 Aug 2022
Group Vaccine brand
5-11 Pfizer (30 micrograms) 2002 0.91
Pfizer (10 micrograms) 217161 99.05
Other 77 0.04
12-15 Pfizer (30 micrograms) 607558 95.95
Pfizer (10 micrograms) 25284 3.99
Other 343 0.05

Notes

  • Patient counts are rounded to nearest 7

  • 'Other' vaccines are Oxford-AZ or Moderna

Summary Charts

Note: The 'In a risk group' includes those identified as being at higher risk of severe COVID-19 (for details see the Group Definitions section).

5-11 population

COVID vaccinations among 5-11 population

by Sex

COVID vaccinations among 5-11 population

by Ethnicity (broad categories)

COVID vaccinations among 5-11 population

by Index of Multiple Deprivation (quintiles)

COVID vaccinations among 5-11 population

by Risk status

12-15 population

COVID vaccinations among 12-15 population

by Sex

COVID vaccinations among 12-15 population

by Ethnicity (broad categories)

COVID vaccinations among 12-15 population

by Index of Multiple Deprivation (quintiles)

COVID vaccinations among 12-15 population

by Risk status

Vaccination rates of each eligible population group, according to demographic/clinical features

Cumulative vaccination figures among 12-15 population

Please refer to footnotes below table for information.

Vaccinated at 10 Aug 2022 (n) Vaccinated at 10 Aug 2022 (%) Total eligible Previous week's vaccination coverage (%) Vaccinated over last 7d (%)
Category Group
overall overall 633,164 53.5 1,184,008 53.4 0.1
Sex F 310,275 53.7 577,899 53.6 0.1
M 322,847 53.3 606,039 53.2 0.1
Ethnicity (broad categories) Black 12,159 29.5 41,258 29.4 0.1
Mixed 15,540 41.0 37,891 41.0 0.0
Other 13,790 42.1 32,739 42.1 0.0
South Asian 53,949 47.6 113,365 47.5 0.1
Unknown 44,786 49.9 89,698 49.9 0.0
White 492,905 56.7 868,980 56.7 0.0
Ethnicity (detailed categories) African 8,330 32.4 25,704 32.4 0.0
Bangladeshi or British Bangladeshi 4,977 49.9 9,968 49.8 0.1
Caribbean 875 18.7 4,690 18.7 0.0
Chinese 3,934 57.6 6,832 57.5 0.1
Other 9,870 38.1 25,928 38.0 0.1
Other Asian 11,585 50.5 22,925 50.4 0.1
British or Mixed British 457,982 59.9 764,512 59.8 0.1
Indian or British Indian 21,469 61.0 35,168 60.9 0.1
Irish 1,015 42.6 2,380 42.6 0.0
Other Black 2,947 27.1 10,857 27.1 0.0
Other White 33,901 33.2 102,088 33.2 0.0
Other mixed 6,090 41.9 14,525 41.9 0.0
Pakistani or British Pakistani 15,911 35.1 45,283 35.0 0.1
Unknown 44,779 49.9 89,698 49.9 0.0
White + Asian 4,627 54.0 8,568 53.8 0.2
White + Black African 2,443 36.6 6,678 36.5 0.1
White + Black Caribbean 2,387 29.4 8,120 29.4 0.0
Index of Multiple Deprivation (quintiles) 1 Most deprived 106,743 38.3 278,796 38.2 0.1
2 110,145 48.3 227,899 48.3 0.0
3 125,594 55.7 225,673 55.6 0.1
4 131,369 61.7 213,038 61.6 0.1
5 Least deprived 141,540 68.3 207,158 68.2 0.1
Unknown 17,731 56.5 31,360 56.5 0.0
Risk status In a risk group 51,373 57.2 89,859 57.1 0.1
Not in a risk group 581,749 53.2 1,094,072 53.1 0.1

Footnotes:

  • Patient counts rounded to the nearest 7.

Cumulative vaccination figures among 5-11 population

Please refer to footnotes below table for information.

Vaccinated at 10 Aug 2022 (n) Vaccinated at 10 Aug 2022 (%) Total eligible Previous week's vaccination coverage (%) Vaccinated over last 7d (%)
Category Group
overall overall 219,163 10.8 2,022,195 10.7 0.1
Sex F 106,533 10.8 985,061 10.7 0.1
M 112,630 10.9 1,037,106 10.7 0.2
Ethnicity (broad categories) Black 3,269 5.0 65,716 4.9 0.1
Mixed 6,650 8.5 78,589 8.3 0.2
Other 5,656 9.8 57,953 9.6 0.2
South Asian 23,506 12.0 195,132 11.8 0.2
Unknown 22,008 10.5 208,852 10.4 0.1
White 158,074 11.2 1,415,925 11.0 0.2
Ethnicity (detailed categories) African 2,345 5.5 42,602 5.4 0.1
Bangladeshi or British Bangladeshi 1,918 11.5 16,611 11.3 0.2
Caribbean 161 2.2 7,175 2.2 0.0
Chinese 2,114 19.3 10,934 19.1 0.2
Other 3,535 7.5 47,026 7.4 0.1
Other Asian 4,515 12.1 37,177 11.9 0.2
British or Mixed British 148,449 11.9 1,243,886 11.8 0.1
Indian or British Indian 13,566 21.0 64,589 20.6 0.4
Irish 336 8.6 3,920 8.4 0.2
Other Black 763 4.8 15,953 4.7 0.1
Other White 9,310 5.5 168,063 5.5 0.0
Other mixed 2,674 8.9 30,030 8.8 0.1
Pakistani or British Pakistani 3,507 4.6 76,741 4.5 0.1
Unknown 21,994 10.5 208,866 10.4 0.1
White + Asian 2,345 12.8 18,319 12.6 0.2
White + Black African 938 7.3 12,852 7.2 0.1
White + Black Caribbean 700 4.0 17,423 3.9 0.1
Index of Multiple Deprivation (quintiles) 1 Most deprived 32,207 6.6 484,596 6.6 0.0
2 36,309 9.2 392,560 9.1 0.1
3 43,253 11.4 380,037 11.2 0.2
4 46,270 13.2 350,637 13.0 0.2
5 Least deprived 51,443 15.6 329,077 15.4 0.2
Unknown 9,688 11.4 85,253 11.2 0.2
Risk status In a risk group 21,350 18.0 118,839 17.8 0.2
Not in a risk group 197,813 10.4 1,903,328 10.2 0.2

Footnotes:

  • Patient counts rounded to the nearest 7.

Appendix

Ethnicity coverage for each eligible group

The table below shows the proportion of each population group for whom ethnicity is known.

  • Ethnicity information is primarily retrieved from GP records.
  • Where missing in GP records, as of March 8 2021, it is then retrieved from hospital records if present.
    • For patients with multiple different ethnicities recorded, we use the most common non-missing ethnicity
      recorded in inpatients, outpatients or A&E over the last ~5 years (or latest if tied).
  • Patient counts are rounded to the nearest 7
total population (n) ethnicity coverage (%)
group
5-11 2022195 89.7
12-15 1184008 92.4